MinYuen T.
- Country
- Ireland
- Department
- Cancer Clinical Trials Unit
Research Overview
- A Randomized Controlled Trial Evaluating the Efficacy of Lutetium (177Lu) Vipivotide Tetraxetan in Patients with Metastatic Hormone-Sensitive Prostate Cancer Receiving Androgen Deprivation Therapy
- Phase 3 Randomized Study of BMS-986365 Versus Docetaxel or Androgen Receptor Pathway Inhibitors in Metastatic Castration-resistant Prostate Cancer
Data & Insights
Has run more than one trial at 10 of 110 partner sites.
Specializations
Oncology Focus
The investigator specializes in treating metastatic castration-resistant prostate cancer, conducting advanced clinical research in this challenging oncological field.
- Prostate Cancer Management
- Advanced Stage Cancer Treatment
- Hormone-Resistant Cancers
Actively engaged in evaluating novel therapeutic approaches for patients with advanced prostate malignancies.
Therapeutic Innovation
The investigator focuses on exploring innovative treatment modalities for patients who have developed resistance to conventional therapies.
- Novel Drug Development
- Comparative Treatment Studies
- Personalized Medicine Approaches
Dedicated to advancing therapeutic options through clinical investigation of emerging treatments.
Clinical Expertise
Demonstrates particular interest in disease progression assessment and therapeutic response evaluation in advanced cancer cases.
- Treatment Response Monitoring
- Disease Management Strategies
- Patient Care Optimization
Focuses on implementing evidence-based approaches in clinical practice.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.